There is no commercial support for this activity.

About the speaker

Dr. Poskar is one of the nation’s leading experts on the treatment of OCD and Related Disorders.  He is a member of the Scientific and Clinical Advisory Board of the International OCD Foundation. He also serves on the faculty of the IOCDF Behavior Therapy Training Institute.  Dr. Poskar co-founded OCD New York, a charity whose mission is to help all those affected by Obsessive Compulsive Disorder (OCD) and Related Disorders to live full and productive lives.

Dr. Poskar is one of the few clinicians in the country with expertise in using both medication and Cognitive Behavioral Therapy to treat OCD and Related Disorders.  Patients are commonly referred to Dr. Poskar by their individual therapists so that he may treat them with medication.  In these cases, Dr. Poskar works closely with each patient’s therapist because he views this collaborative approach to be essential for the provision of the best possible care.

Dr. Poskar is medically licensed in New York and Florida.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services, or off-label uses of product(s) during this presentation.

Steven Poskar, MD, report that he has no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months. He will discuss the off-label use of pharmaceuticals in his presentation. All conflicts have been mitigated through review. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months:  Jon Hershfield, MFT, Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.